RecruitingRecruiting
Predicting Breast Cancer With the BRAVE System
NCT06498388 · Université de Sherbrooke
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Building the Predictive Model of the BRA-based ViscoElastography (BRAVE) System for Detecting Breast Cancer Tumors (BRAVE Discovery Study)
About this study
This study has two objectives, which will be studied in two separate groups.
1. To measure the sensitivity and specificity of BRAVE in identifying malignant lesions in a cohort of 300 women.
2. To assess the impact of breast density on the ability of BRAVE to discriminate malignant breast lesions.
The research team aim to recruit 300 women requiring follow-up imaging. Half will have lower breast density (categories A or B) and the other half will have higher breast density (categories C or D).
Participants will need to attend a single visit lasting approximately 75 minutes, where they will be asked to wear the study's bra and complete the examination process.
Other data will also be collected in the medical file to enable the team to confirm: the density of the breast, and the results and dates of mammography imaging or other tests related to breast cancer.
Eligibility criteria
Inclusion Criteria:
* ≥18 years old
* Able and willing to provide signed informed consent in French or English
* Recent mammogram (\< 6 months)
* Breast mass newly identified by palpation, mammography, sonography, or MRI and have been referred for additional imaging or evaluation.
Specific inclusion Criteria:
Group 1 - Normal Mammographic Breast Density (NMBD): Breast density A or B Group 2 - Elevated Mammographic Breast Density (EMBD): Breast density C or D
Exclusion Criteria:
* Pregnant or breast-feeding women
* Breast implants or prior surgery/biopsy to breasts
* Any disease or condition limiting the capacity to complete the examination process
* Any previous or prescribed treatment against cancer
Study design
Enrollment target: 300 participants
Age groups: adult, older_adult
Timeline
Starts: 2025-01-28
Estimated completion: 2028-12-31
Last updated: 2026-06-01
Interventions
Other: Stiffness measurement by visco-elastography
Primary outcomes
- • Stiffness of the breasts (Once, at recruitment, up to 6 months after mammography)
- • Risk and malignancies lesions (RnMLs) (At the time of mammogram, which will be no more than 6 months prior to recruitment)
Sponsor
Université de Sherbrooke · other
With: Cancer Research Society
Contacts & investigators
ContactAmelie Tetu, MSc · contact · amelie.tetu.ciussse-chus@ssss.gouv.qc.ca · 819-346-1110
InvestigatorElijah Van Houten, PhD, ing. · principal_investigator, Université de Sherbrooke
All locations (1)
CIUSSS de l'Estrie - CHUSRecruiting
Sherbrooke, Quebec, Canada